John Barlow
Analytical Development Director
John Barlow, Analytical Development Director at Cellistic, has been leading analytical development in the cell and gene therapy industry for 8 years. He has led analytical programs on multiple pilot and pivotal stage products at GSK, Promethera and Catalent, including HSC, CarT, TCR-T, NK, MSC, macrophage and iPSC-derived products. . Prior to moving into cell and gene therapy, John spent 7 years leading analytical method development for viral and recombinant-protein based vaccines at GSK.
John holds a Doctorate in Biochemistry from Oxford University.